Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study
Author:
Affiliation:
1. Laboratory of Biocrystallography and Computational Molecular Biology, Department of Physics, Periyar University, Salem, India
Publisher
Informa UK Limited
Subject
Molecular Biology,General Medicine,Structural Biology
Link
https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1786459
Reference52 articles.
1. Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations
2. Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus
3. Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2
4. Adaptive stochastic methods for sampling driven molecular systems
5. Identification of Novel Inhibitors of the SARS Coronavirus Main Protease 3CLpro
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Purification approaches, identification methods and computational tools for bacterial proteases;Biocatalysis and Agricultural Biotechnology;2024-06
2. Computational Estimation of Residues Involving Resistance to the SARS-CoV-2 Main Protease Inhibitor Ensitrelvir Based on Virtual Alanine Scan of the Active Site;Biological and Pharmaceutical Bulletin;2024-05-17
3. The design of compounds with desirable properties – The anti‐ HIV case study;Journal of Computational Chemistry;2022-12-19
4. HIV and SARS-CoV-2 Co-Infection: From Population Study Evidence to In Vitro Studies;Life;2022-12-13
5. Dynamics and binding affinity of nucleoside and non-nucleoside inhibitors with RdRp of SARS-CoV-2: a molecular screening, docking, and molecular dynamics simulation study;Journal of Biomolecular Structure and Dynamics;2022-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3